Fecal immunochemical testing (FIT) was more accurate than blood-based testing for detecting advanced precancerous colorectal ...

Stanford Medicine researchers have developed a blood test capable of detecting cancers, the ways cancer resists treatments and tissue injury caused by non-cancerous conditions. The new test ...

Estimation of population attributable fractions based on integrated global cancer incidence data, 1990-2021. Utilizing cancer community outreach and engagement to explain impact of age, income, ...

Developed by the company’s researchers, the blood test utilises shallow whole-genome sequencing of cell-free DNA.

They have developed a blood-based method called RARE-seq that detects tumor-derived cell-free RNA with around 50 ... outperforming commonly used DNA-based approaches. RNA from vaccines and many ...

Delivery of B7H3-targeted CAR-T cells in injectable silk hydrogels and effects on the efficacy in treating solid tumors. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This ...

An artificial intelligence technique for detecting DNA fragments shed by tumors and circulating in a patient’s blood, ...

For the new cell-free DNA testing, a small amount of a person’s blood is tested for a large number of cancers. A positive test could indicate that the person has a certain type of cancer in ...

This so-called cell free DNA can be used to identify cancer at very early stages. In a breakthrough, scientists have now developed a method for detecting small amounts of cell-free RNA. When a cell is ...

A groundbreaking study published in the Journal of Molecular Diagnostics reports the successful clinical validation of SeekInCare ®, a novel, non-invasive multi-omics blood test designed for the early ...

Dear Dr. Roach: I am 85 and healthy apart from polycythemia vera, for which I take aspirin. I was interested in the new blood test for cancer. Is it worthwhile? Dear M.N.: When screening patients ...